Bufan Xiao

492 total citations
13 papers, 300 citations indexed

About

Bufan Xiao is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Bufan Xiao has authored 13 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Bufan Xiao's work include RNA modifications and cancer (3 papers), CAR-T cell therapy research (3 papers) and Circular RNAs in diseases (3 papers). Bufan Xiao is often cited by papers focused on RNA modifications and cancer (3 papers), CAR-T cell therapy research (3 papers) and Circular RNAs in diseases (3 papers). Bufan Xiao collaborates with scholars based in China, United States and Ethiopia. Bufan Xiao's co-authors include Zhaohao Huang, Ruihao Zhou, Jingtao Zhang, Kaddie Kwok Chen, Cheng Ju, Guofu Huang, Feifei Zhang, Bentong Yu, Zheming Lu and Jingtao Zhang and has published in prestigious journals such as Nature Communications, Macromolecules and International Journal of Molecular Sciences.

In The Last Decade

Bufan Xiao

13 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bufan Xiao China 10 191 156 59 40 32 13 300
Weiqing Lu China 5 185 1.0× 104 0.7× 96 1.6× 38 0.9× 48 1.5× 8 278
Hanhan Shi China 7 242 1.3× 123 0.8× 75 1.3× 20 0.5× 48 1.5× 17 338
Fanqin Bu China 13 252 1.3× 132 0.8× 95 1.6× 75 1.9× 41 1.3× 28 393
Zhengming Zhu China 14 273 1.4× 223 1.4× 48 0.8× 44 1.1× 25 0.8× 23 395
Abigail Hamilton United States 5 214 1.1× 97 0.6× 36 0.6× 25 0.6× 30 0.9× 8 330
Wenmiao Wang China 13 119 0.6× 113 0.7× 122 2.1× 62 1.6× 15 0.5× 30 328
Zhongwei Zhao China 14 178 0.9× 140 0.9× 71 1.2× 98 2.5× 52 1.6× 32 416
Haofan Yin China 11 238 1.2× 127 0.8× 97 1.6× 28 0.7× 34 1.1× 23 357
Ariana von Lersner United States 8 308 1.6× 175 1.1× 51 0.9× 37 0.9× 59 1.8× 8 389

Countries citing papers authored by Bufan Xiao

Since Specialization
Citations

This map shows the geographic impact of Bufan Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bufan Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bufan Xiao more than expected).

Fields of papers citing papers by Bufan Xiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bufan Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bufan Xiao. The network helps show where Bufan Xiao may publish in the future.

Co-authorship network of co-authors of Bufan Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Bufan Xiao. A scholar is included among the top collaborators of Bufan Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bufan Xiao. Bufan Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Han, Haibo, Xuantong Zhou, Tongyang Gong, et al.. (2025). Integrating Bulk and Single-Cell Transcriptomics with Machine Learning Reveals a Heme Metabolism-Based Panel for Lung Adenocarcinoma Chemotherapy Resistance. International Journal of Molecular Sciences. 26(10). 4685–4685. 1 indexed citations
2.
Hwang, Jinhyo, et al.. (2024). Synthesis and Characterization of n-Doped Poly(benzodifurandione) (n-PBDF) Derivatives via Aromatic Substitution. Macromolecules. 57(22). 10717–10724. 1 indexed citations
3.
Zhou, Yangyang, Ze‐Fan Yao, Yang Lu, et al.. (2023). Visualizing the multi-level assembly structures of conjugated molecular systems with chain-length dependent behavior. Nature Communications. 14(1). 3340–3340. 22 indexed citations
5.
Yang, Hong, Bufan Xiao, Ying Xiong, et al.. (2022). circ_0000567/miR-421/TMEM100 Axis Promotes the Migration and Invasion of Lung Adenocarcinoma and Is Associated with Prognosis. Journal of Cancer. 13(5). 1540–1552. 9 indexed citations
6.
Xiao, Bufan, et al.. (2021). Genetically Modified T Cells for Esophageal Cancer Therapy: A Promising Clinical Application. Frontiers in Oncology. 11. 763806–763806. 14 indexed citations
7.
Xiao, Bufan, et al.. (2021). Chimeric Antigen Receptor T-Cell Therapy in Lung Cancer: Potential and Challenges. Frontiers in Immunology. 12. 782775–782775. 34 indexed citations
8.
Zhang, Jingtao, et al.. (2019). Overexpression of Family with Sequence Similarity 83, Member A (FAM83A) Predicts Poor Clinical Outcomes in Lung Adenocarcinoma. Medical Science Monitor. 25. 4264–4272. 12 indexed citations
9.
Zhou, Ruihao, Kaddie Kwok Chen, Jingtao Zhang, et al.. (2018). The decade of exosomal long RNA species: an emerging cancer antagonist. Molecular Cancer. 17(1). 75–75. 134 indexed citations
10.
Yang, Pingping, et al.. (2018). Comparative Efficacy and Safety of Therapies in IgA Nephropathy: A Network Meta-analysis of Randomized Controlled Trials. Kidney International Reports. 3(4). 794–803. 11 indexed citations
11.
Huang, Zhaohao, Chun Cheng, Kaddie Kwok Chen, et al.. (2018). NRP1 promotes cell migration and invasion and serves as a therapeutic target in nasopharyngeal carcinoma.. PubMed. 11(5). 2460–2469. 11 indexed citations
13.
Xiao, Bufan, Jing Jiang, Changqing Liu, et al.. (2017). Recombinant Adenovirus-p53 Gene Therapy for Advanced Unresectable Soft-Tissue Sarcomas. Human Gene Therapy. 29(6). 699–707. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026